Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration

Acta Biomaterialia

Volumn 13, Issue , 2015, Pages 207-215

  Näkki, Simo ^a   Rytkönen, Jussi ^a   Nissinen, Tuomo ^a   Florea, Cristina ^a   Riikonen, Joakim ^a   Ek, Paul ^b   Zhang, Hongbo ^c   Santos, Hélder A ^c   Närvänen, Ale ^a   Xu, Wujun ^a   Lehto, Vesa Pekka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Biocompatilibity; Opsonization; Polyethylene glycol; Porous silicon nanoparticles; Surface modification

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED DRUG DELIVERY; MACROPHAGES; MESOPOROUS MATERIALS; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; PORE SIZE; PROTEINS; SILICON COMPOUNDS; SURFACE TREATMENT; TARGETED DRUG DELIVERY;

BIOCOMPATILIBITY; DRUG CARRIER; INTRAVENOUS APPLICATIONS; NANOSTRUCTURED SILICON; OPSONIZATION; PEGYLATION; POROUS SILICON NANOPARTICLE; PROTEIN ADSORPTION; SILICON NANOPARTICLES; SURFACE-MODIFICATION;

POROUS SILICON;

MACROGOL; NANOCARRIER; NANOCOATING; OPSONIN; PLASMA PROTEIN; SILICA NANOPARTICLE; SODIUM CHLORIDE; THERMALLY OXIDIZED POROUS SILICON NANOPARTICLE; UNCLASSIFIED DRUG; BIOMATERIAL; DRUG CARRIER; MACROGOL DERIVATIVE; NANOMATERIAL; SILICON;

ADSORPTION KINETICS; ARTICLE; BIOCOMPATIBILITY; CELL TRANSPORT; CELL VIABILITY; COLLOID; CONFORMATION; CONTROLLED STUDY; DENSITY; DRUG DELIVERY SYSTEM; HALF LIFE TIME; HUMAN; HUMAN CELL; MACROPHAGE; MOLECULAR STABILITY; MOLECULE; NANOPHARMACEUTICS; OXIDATION; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SURFACE PROPERTY; ANIMAL; CHEMISTRY; HEPG2 CELL LINE; INTRAVENOUS DRUG ADMINISTRATION; MATERIALS TESTING; MOUSE;

BASIDIOMYCOTA;

ANIMALS; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; HALF-LIFE; HEP G2 CELLS; HUMANS; INJECTIONS, INTRAVENOUS; MATERIALS TESTING; MICE; NANOSTRUCTURES; POLYETHYLENE GLYCOLS; SILICON;

EID: 84920718215     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.11.019     Document Type: Article

References (43)

1. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
2. M. Kim, J. Jung, J. Lee, K. Na, S. Park, and J. Hyun Amphiphilic comblike polymers enhance the colloidal stability of Fe3O4 nanoparticles Colloids Surf B: Biointerfaces 76 2010 236 240
3. Q.J. He The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses Biomaterials 31 2010 1085 1092
4. R. Gref 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf B: Biointerfaces 18 2000 301 313
5. C. Fang, B. Shi, Y.-Y. Pei, M.-H. Hong, J. Wu, and H.-Z. Chen In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size Eur J Pharm Sci 27 2006 27 36
6. D.E. Owens III, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int J Pharm 307 2006 93 102
7. S.J. Sofia, V.V. Premnath, and E.W. Merrill Poly(ethylene oxide) grafted to silicon surfaces: grafting density and protein adsorption Macromolecules 31 1998 5059 5070
8. Z.H. Yang, J.A. Galloway, and H.U. Yu Protein interactions with poly(ethylene glycol) self-assembled monolayers on glass substrates: diffusion and adsorption Langmuir 15 1999 8405 8411
9. G. Storm, S.O. Belliot, T. Daemen, and D.D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv Drug Deliv Rev 17 1995 31 48
10. L.T. Canham Bioactive silicon structure fabrication through nanoetching techniques Adv Mater 7 1995 1033 1037
11. L.T. Canham, C.L. Reeves, J.P. Newey, M.R. Houlton, T.I. Cox, and J.M. Buriak Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma Adv Mater 11 1999 1505 1507
12. J. Salonen, A.M. Kaukonen, J. Hirvonen, and V.-P. Lehto Mesoporous silicon in drug delivery applications J Pharm Sci 97 2008 632 653
13. S.C. Bayliss, R. Heald, D.I. Fletcher, and L.D. Buckberry The culture of mammalian cells on nanostructured silicon Adv Mater 11 1999 318 321
14. S.H.C. Anderson, H. Elliot, D.J. Wallis, L.T. Canham, and J.J. Powell Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions Phys Status Solidi A 197 2003 331 335
15. R. Jugdaohsingh, K.L. Tucker, N. Qiao, L.A. Cupples, D.P. Kiel, and J.J. Powell Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham offspring cohort J Bone Miner Res 19 2003 297 307
16. J. Salonen Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs J Control Release 108 2005 362 374
17. T. Limnell, J. Riikonen, J. Salonen, A. Kaukonen, L. Laitinen, and J. Hirvonen Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles Int J Pharm 343 2007 141 147
18. L.M. Bimbo, E. Mäkilä, T. Laaksonen, V.-P. Lehto, J. Salonen, and J. Hirvonen Drug permeation across intestinal epithelial cells using porous silicon nanoparticles Biomaterials 32 2011 2625 2633
19. E. Tasciotti Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications Nat Nanotechnol 3 2008 151 157
20. J.H. Park, L. Gu, G. von Maltzahn, E. Ruoslahti, S.N. Bhatia, and M.J. Sailor Biodegradable luminescent porous silicon nanoparticles for in vivo applications Nat Mater 8 2009 331 336
21. A.S.-W. Goh A novel approach to brachytherapy in hepatocellular carcinoma using a phosphorous32 (32P) brachytherapy delivery device - a first-in-man study Int J Radiat Oncol 67 2007 786 792
22. B. Godin Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation J Biomed Mater Res A 94A 2010 1236 1243
23. Y. Liu, K. Yehl, Y. Narui, and K. Salaita Tension sensing nanoparticles for mechano-imaging at the living/nonliving interface J Am Chem Soc 135 2013 5320 5323
24. L.M. Bimbo Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats Acs Nano 4 2010 3023 3032
25. J. Rytkönen, R. Miettinen, M. Kaasalainen, V.-P. Lehto, J. Salonen, and A. Närvänen Functionalization of mesoporous silicon nanoparticles for targeting and bioimaging purposes J Nanomater 2012 2012 9
26. S.I. Jeon, J.H. Lee, J.D. Andrade, and P.G. Degennes Protein-surface interactions in the presence of polyethylene oxide.1. Simplified theory J Colloid Interface Sci 142 1991 149 158
27. J.V. Jokerst, T. Lobovkina, R.N. Zare, and S.S. Gambhir Nanoparticle PEGylation for imaging and therapy Nanomedicine 6 2011 715 728
28. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 2000 271 284
29. M.L. Etheridge, S.A. Campbell, A.G. Erdman, C.L. Haynes, S.M. Wolf, and J. McCullough The big picture on nanomedicine: the state of investigational and approved nanomedicine products Nanomed-Nanotechnol 9 2013 1 14
30. T. Maldiney, C. Richard, J. Seguin, N. Wattier, M. Bessodes, and D. Scherman Effect of core diameter, surface coating, and PEG chain length on the biodistribution of persistent luminescence nanoparticles in mice Acs Nano 5 2011 854 862
31. G. Sonavane, K. Tomoda, and K. Makino Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size Colloids Surf B 66 2008 274 280
32. J. Riikonen Surface chemistry, reactivity, and pore structure of porous silicon oxidized by various methods Langmuir 28 2012 10573 10583
33. W. Xu Amine surface modifications and fluorescent labeling of thermally stabilized mesoporous silicon nanoparticles J Phys Chem C 116 2012 22307 22314
34. G. Kister, G. Cassanas, and M. Vert Effects of morphology, conformation and configuration on the IR and raman spectra of various poly(lactic acid)s Polymer 39 1998 267 273
35. P.J. Kinnari Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy Biomaterials 34 2013 9134 9141
36. Y. Sheng, Y. Yuan, C.S. Liu, X.Y. Tao, X.Q. Shan, and F. Xu In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content J Mater Sci Mater Med 20 2009 1881 1891
37. E. Ostuni, R.G. Chapman, R.E. Holmlin, S. Takayama, and G.M. Whitesides A survey of structure-property relationships of surfaces that resist the adsorption of protein Langmuir 17 2001 5605 5620
38. P. Aggarwal, J.B. Hall, C.B. McLeland, M.A. Dobrovolskaia, and S.E. McNeil Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy Adv Drug Del Rev 61 2009 428 437
39. J.C. Leroux, F. De Jaeghere, B. Anner, E. Doelker, and R. Gurny An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D, L-lactic acid) nanoparticles by human monocytes Life Sci 57 1995 695 703
40. T.M. Goppert, and R.H. Muller Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting Int J Pharm 302 2005 172 186
41. P. Camner, M. Lundborg, L. Lastbom, P. Gerde, N. Gross, and C. Jarstrand Experimental and calculated parameters on particle phagocytosis by alveolar macrophages J Appl Physiol 92 2002 2608 2616
42. M. Sarparanta Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution Mol Pharm 9 2012 654 663
43. T. Yu, A. Malugin, and H. Ghandehari Impact of silica nanoparticle design on cellular toxicity and hemolytic activity Acs Nano 5 2011 5717 5728